These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 17400919

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Probing the local conformational change of alpha1-antitrypsin.
    Baek JH, Im H, Kang UB, Seong KM, Lee C, Kim J, Yu MH.
    Protein Sci; 2007 Sep; 16(9):1842-50. PubMed ID: 17660256
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of positively charged residues contributing to the stability of plasminogen activator inhibitor 1.
    Gils A, Lu J, Aertgeerts K, Knockaert I, Declerck PJ.
    FEBS Lett; 1997 Sep 29; 415(2):192-5. PubMed ID: 9350994
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mutational analysis of plasminogen activator inhibitor-1.
    Wind T, Jensen JK, Dupont DM, Kulig P, Andreasen PA.
    Eur J Biochem; 2003 Apr 29; 270(8):1680-8. PubMed ID: 12694181
    [Abstract] [Full Text] [Related]

  • 11. Interactions causing the kinetic trap in serpin protein folding.
    Im H, Woo MS, Hwang KY, Yu MH.
    J Biol Chem; 2002 Nov 29; 277(48):46347-54. PubMed ID: 12244055
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion.
    Sharp AM, Stein PE, Pannu NS, Carrell RW, Berkenpas MB, Ginsburg D, Lawrence DA, Read RJ.
    Structure; 1999 Feb 15; 7(2):111-8. PubMed ID: 10368279
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
    Xue Y, Björquist P, Inghardt T, Linschoten M, Musil D, Sjölin L, Deinum J.
    Structure; 1998 May 15; 6(5):627-36. PubMed ID: 9634700
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preparation and characterization of latent alpha 1-antitrypsin.
    Lomas DA, Elliott PR, Chang WS, Wardell MR, Carrell RW.
    J Biol Chem; 1995 Mar 10; 270(10):5282-8. PubMed ID: 7890640
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distribution of the native strain in human alpha 1-antitrypsin and its association with protease inhibitor function.
    Seo EJ, Im H, Maeng JS, Kim KE, Yu MH.
    J Biol Chem; 2000 Jun 02; 275(22):16904-9. PubMed ID: 10747976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.